Lei Yao Selected Research

Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)

12/2019	HuoXue QianYang QuTan Recipe attenuates left ventricular hypertrophy in obese hypertensive rats by improving mitochondrial function through SIRT1/PGC-1α deacetylation pathway.
2/2010	Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Yao Research Topics

Disease

55	Neoplasms (Cancer) 03/2022 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2010
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2003
11	Glioma (Gliomas) 01/2019 - 11/2011
9	Inflammation (Inflammations) 01/2022 - 01/2006
8	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2011
6	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 03/2003
6	Infections 10/2021 - 06/2013
5	Myocardial Infarction 01/2022 - 10/2009
5	Hemorrhage 01/2018 - 08/2011
5	Brain Neoplasms (Brain Tumor) 07/2016 - 01/2012
4	Cholangiocarcinoma 01/2022 - 01/2015
4	Hypertension (High Blood Pressure) 01/2022 - 08/2010
4	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 02/2013
4	Reperfusion Injury 12/2021 - 04/2012
4	Fibrosis (Cirrhosis) 12/2021 - 07/2008
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
4	Adenocarcinoma 01/2020 - 01/2011
4	Body Weight (Weight, Body) 12/2019 - 06/2009
4	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 06/2013
4	Radiation Pneumonitis 12/2014 - 08/2010
3	Ischemia 01/2022 - 06/2009
3	Obesity 01/2022 - 01/2018
3	Chronic Pain 10/2020 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2013
3	Vitiligo 10/2017 - 12/2012
2	Pain (Aches) 02/2022 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 12/2021 - 11/2021
2	Wounds and Injuries (Trauma) 12/2021 - 01/2021
2	Hypertrophy 12/2021 - 11/2007
2	Sporotrichosis 10/2021 - 12/2020
2	Acute Lung Injury 05/2021 - 06/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Pathologic Processes 01/2021 - 10/2020
2	Carcinogenesis 01/2021 - 01/2018
2	Mycoses (Diseases, Fungus) 12/2020 - 02/2014
2	Hepatitis 01/2020 - 01/2012
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2019 - 02/2010
2	Esophageal Neoplasms (Esophageal Cancer) 04/2018 - 11/2016
2	Calculi (Calculus) 12/2016 - 10/2016

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 03/2022 - 03/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
12	ORALIT (ORS)IBA 01/2012 - 07/2010
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
8	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2010
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 11/2011
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
6	Peptides (Polypeptides)IBA 01/2014 - 01/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2012
5	Therapeutic UsesIBA 12/2021 - 12/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 11/2004
5	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 03/2014 - 01/2013
4	huoxue qianyangIBA 01/2022 - 12/2019
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 08/2019
4	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 01/2013
3	Volatile Oils (Essential Oils)IBA 04/2022 - 06/2013
3	Circular RNAIBA 01/2022 - 01/2021
3	Sirtuin 1IBA 01/2022 - 12/2019
3	Long Noncoding RNAIBA 12/2021 - 01/2019
3	CytokinesIBA 12/2021 - 12/2012
3	ChemokinesIBA 01/2021 - 04/2002
3	Amyloid beta-PeptidesIBA 03/2016 - 03/2014
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2014 - 03/2012
3	arginylprolineIBA 12/2011 - 09/2010
3	prolyl-proline (Pro-Pro)IBA 12/2011 - 09/2010
3	arginylarginine (Arg-Arg)IBA 12/2011 - 09/2010
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2010 - 07/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 03/2017
2	CholesterolIBA 01/2022 - 10/2020
2	InflammasomesIBA 12/2021 - 10/2020
2	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 10/2021 - 09/2013
2	Melanins (Melanin)IBA 10/2021 - 03/2021
2	Caspase 3 (Caspase-3)IBA 08/2021 - 01/2021
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2021 - 01/2004
2	SolutionsIBA 01/2021 - 07/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2013
2	LipidsIBA 06/2020 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020 - 07/2010
2	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 01/2018
2	AntigensIBA 01/2020 - 01/2018
2	CannabinoidsIBA 01/2020 - 01/2018
2	CurcuminIBA 01/2019 - 05/2017
2	Clostridium perfringens epsilon-toxinIBA 01/2018 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 09/2002
2	AlbuminsIBA 07/2017 - 01/2016

Therapy/Procedure

19	Therapeutics 04/2022 - 09/2002
5	Drug Therapy (Chemotherapy) 03/2022 - 08/2010
5	Radiotherapy 07/2016 - 12/2012
4	Stents 01/2021 - 10/2016
4	Transplantation 10/2017 - 11/2004
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 12/2020
3	Immunotherapy 01/2022 - 01/2018
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2016 - 08/2011
3	Conformal Radiotherapy 12/2014 - 08/2010
2	Catheter Ablation 07/2021 - 07/2019
2	Analgesia 10/2020 - 01/2018
2	Aftercare (After-Treatment) 12/2019 - 10/2018
2	Chemoradiotherapy 04/2018 - 07/2014